Recent Finacing
Recent Raise
Ousia Pharma develops peptide–small-molecule conjugates combining NMDA receptor modulators with incretin hormone analogues to target neuroplasticity in appetite-regulating neurons; lead dual-incretin/NMDA antagonist is in preclinical to early clinical development.
